Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

Overview of attention for article published in Cancer (0008543X), November 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 1 news outlet

twitter: 39 X users

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 48 X posts from 39 X users, with an upper bound of 97,283 followers.

RT @JournalCancer: Featured in CANCER | In pats w/ retroperitoneal sarcoma, response to neoadjuvant systemic therapy is overall fair. An in…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 44 additional X posts.